We are live on ! Find out more
TGI

TRV GP II Portfolio holdings

AUM $1.34M
1-Year Est. Return 67.55%
This Fund
S&P 500
This Quarter Est. Return
-22.77%
1 Year Est. Return
-67.55%
3 Year Est. Return
-20.84%
5 Year Est. Return
-49.87%
10 Year Est. Return
–
AUM
$1.34M
AUM Growth
-$3.28M
Cap. Flow
-$3.28M
Cap. Flow %
-244.59%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
+$2.74M
2
ALNA
Allena Pharmaceuticals
ALNA
+$533K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNCE
1
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1.34M 100%
572,829
-775,000
-57% -$2.74M
ALNA
2
DELISTED
Allena Pharmaceuticals
ALNA
– –
-2,790,964
Closed -$533K

Similar funds

IVAV
Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return
VM
Value Monitoring Menlo Park, California $1.5M AUM 13.21% 1-Year Est. Return
CL
CRV LLC Palo Alto, California $1.56M AUM 87.36% 1-Year Est. Return
GAM
GVO Asset Management Zug, Switzerland $1.07M AUM 24.36% 1-Year Est. Return
MC
Manteio Capital Jersey City, New Jersey $1.05M AUM
NC
Noked Capital Tel Aviv, Israel $946K AUM 17.1% 1-Year Est. Return
HCIG
H Capital II GP Grand Cayman, Cayman Islands $1.83M AUM
NP
Nimble Partners San Francisco, California $556K AUM 61.7% 1-Year Est. Return

TRV GP II's Q3 2022 Portfolio in Review

As of Q3 2022, TRV GP II held 2 positions worth $1.34M, down 71% from $4.62M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRV GP II withdrew a net $3.28M in Q3 2022, closing 1 position and reducing 1 holding. Its most notable exit was Allena Pharmaceuticals, an estimated $533K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP II's biggest Q3 2022 reduction was Jounce Therapeutics, Inc. Common Stock, cutting an estimated $2.74M.
  • TRV GP II fully exited Allena Pharmaceuticals in Q3 2022, selling an estimated $533K.
  • TRV GP II's ten largest holdings make up 100% of its $1.34M portfolio in Q3 2022.
  • TRV GP II opened 0 new positions and closed 1 in Q3 2022.
  • TRV GP II's portfolio value fell 71% quarter-over-quarter to $1.34M.

Based on TRV GP II's 13F filing for Q3 2022, filed 3 Nov 2022.